Treatment with inhaled a1-antitrypsin: a square peg in a round hole? Source: Eur Respir J, 54 (5) 1901894; 10.1183/13993003.01894-2019 Year: 2019
A small volume valved holding chamber (VHC) manufactured from charge dissipative materials has comparable in vitro performance with a large volume non-conducting plastic spacer for both bronchodilator and anti-inflammatory formulations Source: Eur Respir J 2005; 26: Suppl. 49, 340s Year: 2005
Stability of NO in mylar bags: effect of storage conditions Source: Eur Respir J 2002; 20: Suppl. 38, 141s Year: 2002
Radiographic findings in the employees of five French plants manufacturing glasswool (GW) and rockwool (RW): results of a cross sectional study Source: Eur Respir J 2005; 26: Suppl. 49, 703s Year: 2005
Lung-lining fluid proteins bind to ultrafine insoluble particles: a potential way for particles to pass air-blood barrier of the lung? Source: Eur Respir J 2004; 24: Suppl. 48, 100s Year: 2004
Dose proportionality of in vitro fine particle dose for dry powder inhaler combination products Source: Eur Respir J 2002; 20: Suppl. 38, 541s Year: 2002
Delivery of a suspension corticosteroid formulation by small volume nebulizers: a comparative bench study Source: Eur Respir J 2001; 18: Suppl. 33, 134s Year: 2001
A novel submicron budesonide suspension demonstrates equivalent nebulization times compared to cyclodextrin-based solution formulations Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008
Late Breaking Abstract - Life cycle assessment (LCA) and cradle-to-grave carbon footprint of a multidose reservoirdry powder inhaler product family Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021
Are patients with cystic fibrosis of six years and older able to use dry powder inhalers? A study of the effect of device resistance on flows and volumes Source: Eur Respir J 2004; 24: Suppl. 48, 386s Year: 2004
The genuair® inhaler, a novel multidose dry powder inhaler, demonstrates consistent aerodynamic precision Source: Annual Congress 2009 - New aspects of inhalation therapy Year: 2009
Group 5 drugs for multidrug-resistant tuberculosis: is the glass half full or half empty? Source: Eur Respir J 2017; 49(1): 1602273; DOI: 10.1183/13993003.02273-2016 Year: 2017
Development of a powder for inhalation with R,R-Glycopyrrolate as active ingredient for the delivery from a novel multidose dry powder inhaler Source: Eur Respir J 2003; 22: Suppl. 45, 471s Year: 2003
Comparison of total and fine drug particle mass generated from two dry powder inhalers (DPIs) by 4-year old children with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 429s Year: 2002
Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study Source: Eur Respir J 2011; 38: 1071-1080 Year: 2011
Late Breaking Abstract: Denufosol: A novel ion channel regulator and investigational early-intervention therapy for cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010
Priming of a non-conducting valved holding chamber (VHC) is formulation dependent and may result in inconsistent medication delivery Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology Year: 2007
Antistatic treatment and the amount of salbutamol actuated have variable effect on drug delivery of six different valved holding chambers (VHC) Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019
Not all antistatic valved holding chambers have equivalent performance: An example why each valved holding chamber (VHC)-inhaler combination should be considered unique Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012
The mesh nebuliser: a recent technical innovation for aerosol delivery Source: ISSN=ISSN 1810-6838, ISBN=, page=252 Year: 2006